Aviva offloads stake in life insurance joint venture
Aviva is selling its 50% stake in life insurance joint venture Antarius to French bank Société Générale, for £425m (€500m).
Aviva
473.90p
16:40 04/10/24
FTSE 100
8,280.63
16:49 04/10/24
FTSE 350
4,570.17
17:14 04/10/24
FTSE All-Share
4,527.24
16:54 04/10/24
Life Insurance
5,695.46
17:14 04/10/24
The sale of Antarius, which is currently owned by Aviva and Crédit du Nord, a subsidiary of Société Générale, which took up its option to buy Aviva's stake in Antarius in 2015.
With regulatory approval already received, the sale is expected to close on 1 April.
As part of the deal, Aviva Investors France has agreed with SocGen subsidiary Sogecap to continue managing the €10bn worth of assets held by Antarius.
The £425m sale price represents about 1.7 times Aviva's share of the net asset value of Antarius and 16.4 times Aviva's share of Antarius’ earnings after tax.
At roughly £180m more than Aviva's book value it further increases Solvency II capital by about £200m.
Aviva chief executive Mark Wilson said: "This is a good deal at an attractive valuation and the sale realises a strong return for our shareholders. We have also agreed a new investment management mandate with Antarius and we look forward to continuing our long and successful partnership with Société Générale."